Accelerated scientific-technical advice on medicines against COVID-19
April 1, 2022
Since the start of the COVID-19 health crisis, the FAMHP has given the highest priority to requests for national scientific-technical advice (STA) on medicines against COVID-19. The National Innovation Office and Scientific-Technical Advice Unit uses accelerated timelines for requests regarding medicines that prevent or cure COVID-19 infections. These timelines are crucial to support accelerated clinical research on new medicines against COVID-19.
The FAMHP has formalised the new procedures for the accelerated processing of applications for national STA for medicines against COVID-19. A formal request for accelerated STA can be submitted according to the provisions in article 4 of the Law of 8 February 2022(link is external). These provisions apply to national STA requests with regard to the research and development of medicines for human use that prevent or cure COVID-19 infections (including combination products that fall under the category of medicines).